Theodore S Nowicki
机构: University of California, Los Angeles
每年引用次数
引用次数
引用: 2,004
H-指数: 16
I10-指数 : 21
出版物: 61
The indirect measurement of biomechanical forces in the moving human body
Melanie Cluss , Kenneth Laws , Natalie Martin , T. Scott Nowicki
American Journal of Physics 74 ( 2) 102 -108
14
2006
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy.
Lee D Cranmer , Stanley R Riddell , Venu G Pillarisetty , Erik A Farrar
Journal for ImmunoTherapy of Cancer 9 ( 5)
2021
Increased Estrogen and the Risk of Papillary Thyroid Cancer
Vikas Mehta , Sarah L. Cooke , Guopei Yu , Theodore Scott Nowicki
Laryngoscope 120
2010
Clinical Response with Sunitinib Therapy in the Treatment of Anaplastic Thyroid Cancer
Kenneth M. Wong , Theodore Scott Nowicki , Carmelo Puccio , Tauseef Ahmed
Journal of Cancer Therapy 3 ( 2) 132 -136
2012
Early Recognition of Renal Toxicity of High-dose Methotrexate Therapy: A Case Report
Theodore Scott Nowicki , Kari Bjornard , David Kudlowitz , Claudio Sandoval
Journal of Pediatric Hematology Oncology 30 ( 12) 950 -952
7
2008
Ancestral diversity is limited in published T cell receptor sequencing studies
Yu-Ning Huang , Kerui Peng , Alice B Popejoy , Jieting Hu
Immunity 54 ( 10) 2177 -2179
3
2021
Lack of diversity in T cell receptor sequencing studies
Yu-Ning Huang , Kerui Peng , Alice B Popejoy , Jieting Hu
OSF
Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy
Katie M Campbell , Maneesha Thaker , Egmidio Medina , Anusha Kalbasi
Journal for Immunotherapy of Cancer 10 ( 3)
6
2022
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade
Luke Frankiw , Arun Singh , Cole Peters , Begoña Comin-Anduix
Journal for immunotherapy of cancer 11 ( 5)
5
2023
Systems and Methods for Digital Pathology
Bahram Jalali , Madhuri Suthar , Cejo Konuparamban Lonappan , Antoni Ribas
2022
The urokinase plasminogen activator system in papillary thyroid carcinoma: A metastatic biomarker and potential therapeutic target
Theodore Scott Nowicki
New York Medical College
2013
The Urokinase Plasminogen Activator System in Papillary Thyroid Cancer: A Metastatic Biomarker and Potential Therapeutic Target
Theodore Scott Nowicki
New York Medical College
2011
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
Jennifer L McQuade , Carrie R Daniel , Kenneth R Hess , Carmen Mak
Lancet Oncology 19 ( 3) 310 -322
418
2018
Epigenetic suppression of transgenic T-cell receptor (TCR) expression in adoptive cell transfer (ACT) therapy
Theodore S Nowicki , Colin Farrell , Marco Morselli , Liudmilla Rubbi
Cancer Research 80 ( 16\_Supplement) 6590 -6590
2020
Multiomics analyses reveal functional DNA, methylation pattern changes in clinical transgenic T-cell receptor cell therapy products
Giulia Protti , Cole Peters , Moe Kawakami , Conner Kidd
Cancer Research 84 ( 6_Supplement) 3 -3
2024
Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencing
Kerui Peng , Theodore S Nowicki , Katie Campbell , Mohammad Vahed
Briefings in Bioinformatics 24 ( 4) bbad220 -bbad220
7
2023
The association of BMI and outcomes in metastatic melanoma: A retrospective, multicohort analysis of patients treated with targeted therapy, immunotherapy, or chemotherapy
Jennifer L McQuade , Carrie R Daniel , Kenneth R Hess , Carmen Mak
The Lancet. Oncology 19 ( 3) 310 -310
15
2018
increased expression of KLK7 and KLK10 in papillary thyroid cancer
Melanie MacEwan , Vikas Mehta , E Ashley Darr , Suqing Xie
Cancer Research 71 ( 8_Supplement) 1502 -1502
1
2011
Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis
Selena Ferrian , Candace C Liu , Erin F McCaffrey , Rashmi Kumar
Cell Reports Medicine 2 ( 10)
14
2021
A pilot study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for Her2-negative breast cancer
Vina P Nguyen , Katie M Campbell , Theodore S Nowicki , Nila Elumalai
Cancer Research Communications 3 ( 8) 1628 -1637
3
2023